DE602004001994D1 - Verwendung des proteins masp als marker für kolorektale karzinome - Google Patents

Verwendung des proteins masp als marker für kolorektale karzinome

Info

Publication number: DE602004001994D1
Authority: DE; Germany
Prior art keywords: masp; marker; diagnosis; colorectal carcinomas; colorectal cancer
Prior art date: 2003-05-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE602004001994T

Other languages

English (en)

Other versions

DE602004001994T2 (de

Inventor

Peter Berndt

Marie-Luise Hagmann

Hanno Langen

Stefan Palme

Markus Roessler

Wolfgang Rollinger

Michael Tacke

Werner Zolg

Johann Karl

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Roche Diagnostics GmbH

Original Assignee

F Hoffmann La Roche AG

Roche Diagnostics GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-26

Filing date

2004-05-25

Publication date

2006-09-28

2004-05-25 Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG

2006-09-28 Publication of DE602004001994D1 publication Critical patent/DE602004001994D1/de

2007-09-13 Application granted granted Critical

2007-09-13 Publication of DE602004001994T2 publication Critical patent/DE602004001994T2/de

2024-05-26 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- G01N33/57535—
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE602004001994T 2003-05-26 2004-05-25 Verwendung des proteins masp als marker für kolorektale karzinome Expired - Lifetime DE602004001994T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03011158		2003-05-26
EP03011158		2003-05-26
PCT/EP2004/005598 WO2004104593A1 (en)	2003-05-26	2004-05-25	Use of protein masp as a marker for colorectal cancer

Publications (2)

Publication Number	Publication Date
DE602004001994D1 true DE602004001994D1 (de)	2006-09-28
DE602004001994T2 DE602004001994T2 (de)	2007-09-13

Family

ID=33462076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602004001994T Expired - Lifetime DE602004001994T2 (de)	2003-05-26	2004-05-25	Verwendung des proteins masp als marker für kolorektale karzinome

Country Status (9)

Country	Link
US (1)	US20060121540A1 (de)
EP (1)	EP1631826B1 (de)
JP (1)	JP4241822B2 (de)
CN (1)	CN100504393C (de)
AT (1)	ATE353544T1 (de)
CA (1)	CA2523690C (de)
DE (1)	DE602004001994T2 (de)
ES (1)	ES2271892T3 (de)
WO (1)	WO2004104593A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1831696B1 (de)	2004-12-23	2009-03-18	Roche Diagnostics GmbH	Verwendung von asc als marker für kolorektalkarzinome
EP1831695B1 (de) *	2004-12-23	2009-05-06	F. Hoffmann-La Roche AG	Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
JP4891326B2 (ja) *	2005-10-04	2012-03-07	テレフオンアクチーボラゲットエルエムエリクソン（パブル）	正しい制御ノードへのｉｐ接続の無線基地局のリダイレクション
EP2680003A1 (de) *	2012-06-28	2014-01-01	Fundació Institut d'Investigació Biomèdica de Bellvitge	Serum-Biomarker zur Diagnose eines kolorektalen Karzinoms
ES2619116B1 (es) *	2015-12-23	2018-04-12	Fundación Para La Investigación Biomédica Del Hospital Universitario 12 De Octubre	Biomarcador para el diagnóstico, pronóstico y seguimiento de cáncer colorrectal de aparición precoz
CN107227366B (zh) *	2017-07-05	2020-05-19	昆明医科大学第一附属医院	多功能转录调控因子ctcf的dna结合位点ctcf_113的应用
CN108562746A (zh) *	2018-04-08	2018-09-21	深圳市盛波尔生命科学技术有限责任公司	Cnpy2异构体2在结直肠癌诊断、预后、复发转移及放化疗疗效预测中的应用
GB201907663D0 (en) *	2019-05-30	2019-07-17	Ab Mavatar	Method for diagnosing colorectal cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470970A (en) *	1991-02-28	1995-11-28	Dana-Farber Cancer Institute, Inc.	Maspin, a serpin with tumor suppresing activity
US20020182191A1 (en) *	1998-12-23	2002-12-05	Corixa Corporation	Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AUPP713498A0 (en) *	1998-11-17	1998-12-10	Chandler, Howard Milne	A method of detecting blood

2004
- 2004-05-25 WO PCT/EP2004/005598 patent/WO2004104593A1/en not_active Ceased
- 2004-05-25 DE DE602004001994T patent/DE602004001994T2/de not_active Expired - Lifetime
- 2004-05-25 EP EP04734663A patent/EP1631826B1/de not_active Expired - Lifetime
- 2004-05-25 ES ES04734663T patent/ES2271892T3/es not_active Expired - Lifetime
- 2004-05-25 JP JP2006500105A patent/JP4241822B2/ja not_active Expired - Fee Related
- 2004-05-25 CN CNB2004800143194A patent/CN100504393C/zh not_active Expired - Fee Related
- 2004-05-25 CA CA2523690A patent/CA2523690C/en not_active Expired - Fee Related
- 2004-05-25 AT AT04734663T patent/ATE353544T1/de active
2005
- 2005-11-23 US US11/287,575 patent/US20060121540A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN100504393C (zh)	2009-06-24
US20060121540A1 (en)	2006-06-08
EP1631826A1 (de)	2006-03-08
DE602004001994T2 (de)	2007-09-13
EP1631826B1 (de)	2006-08-16
CA2523690A1 (en)	2004-12-02
JP4241822B2 (ja)	2009-03-18
JP2006524794A (ja)	2006-11-02
ES2271892T3 (es)	2007-04-16
CN1795385A (zh)	2006-06-28
ATE353544T1 (de)	2006-09-15
CA2523690C (en)	2011-05-03
WO2004104593A1 (en)	2004-12-02

Similar Documents

Publication	Publication Date	Title
ATE471512T1 (de)	2010-07-15	Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
DE60315715D1 (de)	2007-09-27	Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE554389T1 (de)	2012-05-15	Apex als marker für lungenkrebs
DE602006007703D1 (de)	2009-08-20	Verbesserte immuntestverfahren
ATE523777T1 (de)	2011-09-15	System und verfahren zur bestimmung der analytkonzentration mittels zeitaufgelöster amperometrie
CY1112553T1 (el)	2016-02-10	Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
ATE541054T1 (de)	2012-01-15	Bio-barcode erkennung für zielmoleküle
ATE431854T1 (de)	2009-06-15	Auf bio-barcodes beruhender nachweis von zielanalyten
CA2701341A1 (en)	2009-05-28	Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE468535T1 (de)	2010-06-15	Verwendung von nnmt als marker für lungenkrebs
DE602005014386D1 (de)	2009-06-18	Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
EP2074427A4 (de)	2010-01-27	Diagnostik-biomolekül(e)
DE60325382D1 (de)	2009-01-29	Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de)	2008-12-04	Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE602004001994D1 (de)	2006-09-28	Verwendung des proteins masp als marker für kolorektale karzinome
ATE462803T1 (de)	2010-04-15	Kit und verfahren zum nachweis von urothelkarzinom
ATE534037T1 (de)	2011-12-15	Verwendung des proteins asc als marker für brustkrebs
ATE503846T1 (de)	2011-04-15	Verfahren zur diagnose eines ovarialkarzinoms
DE602005013430D1 (de)	2009-04-30	Verwendung von asc als marker für kolorektalkarzinome
ATE359516T1 (de)	2007-05-15	Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
ATE393393T1 (de)	2008-05-15	Verwendung des proteins spee als marker für brustkrebs
ATE418737T1 (de)	2009-01-15	Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
DE602004017017D1 (de)	2008-11-20	Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
FR2894675B1 (fr)	2008-06-27	Distinction des meningites bacteriennes et virales
DE602005014659D1 (de)	2009-07-09	Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Legal Events

Date	Code	Title	Description
2007-08-09	8327	Change in the person/name/address of the patent owner	Owner name: ROCHE DIAGNOSTICS GMBH, 68305 MANNHEIM, DE
2007-09-06	8364	No opposition during term of opposition